North America Cellular Immunotherapy Market Size & Outlook
North America cellular immunotherapy market, 2018-2030 (US$M)
Related Markets
North America cellular immunotherapy market highlights
- The North America cellular immunotherapy market generated a revenue of USD 3,073.8 million in 2022.
- The market is expected to grow at a CAGR of 20.6% from 2023 to 2030.
- In terms of segment, car t cell therapy was the largest revenue generating therapy type in 2022.
- CAR T Cell Therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 3,073.8 million |
| Market revenue in 2030 | USD 13,774.7 million |
| Growth rate | 20.6% (CAGR from 2022 to 2030) |
| Largest segment | Car t cell therapy |
| Fastest growing segment | CAR T Cell Therapy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy |
| Key market players worldwide | BioTelemetry, Biotricity Inc, Welch Allyn, Boston Scientific Corp, ZOLL Medical Corporation, IRhythm Technologies Inc, ACS Diagnostics, Medicomp, Telerhythmics |
Other key industry trends
- In terms of revenue, North America region accounted for 40.8% of the global cellular immunotherapy market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,288.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cellular Immunotherapy Market Scope
Cellular Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America cellular immunotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular immunotherapy market will help companies and investors design strategic landscapes.
Car t cell therapy was the largest segment with a revenue share of 71.32% in 2022. Horizon Databook has segmented the North America cellular immunotherapy market based on car t cell therapy, dendritic cell therapy, nk cell therapy, til therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018-2030)
- CAR T Cell Therapy
- Dendritic Cell Therapy
- NK Cell Therapy
- TIL Therapy
- Others
- North America Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018-2030)
- B-cell Malignancies
- Prostate Cancer
- Liver Cancer
- Renal Cell Carcinoma
- Others
- North America Cellular Immunotherapy End Use Outlook (Revenue, USD Million, 2018-2030)
- Others
- Hospitals
- Cancer Institutes
Reasons to subscribe to North America cellular immunotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America cellular immunotherapy market databook
-
Our clientele includes a mix of cellular immunotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cellular immunotherapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America cellular immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America cellular immunotherapy market size, by country, 2018-2030 (US$M)
North America Cellular Immunotherapy Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
